BKHAR vs MRNA · $1.8M cap vs rev $145.0M
Black Hawk Acquisition Corporation Rights (BKHAR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Black Hawk Acquisition Corporation Rights (BKHAR) common stock listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
BKHAR does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
BKHAR currently screens at market cap $1.8M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BKHAR and MRNA stock pages for the full models.
Not investment advice.